Cargando…
Screening Cancer Immunotherapy: When Engineering Approaches Meet Artificial Intelligence
Immunotherapy is a class of promising anticancer treatments that has recently gained attention due to surging numbers of FDA approvals and extensive preclinical studies demonstrating efficacy. Nevertheless, further clinical implementation has been limited by high variability in patient response to d...
Autores principales: | Zhou, Xingwu, Qu, Moyuan, Tebon, Peyton, Jiang, Xing, Wang, Canran, Xue, Yumeng, Zhu, Jixiang, Zhang, Shiming, Oklu, Rahmi, Sengupta, Shiladitya, Sun, Wujin, Khademhosseini, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539186/ https://www.ncbi.nlm.nih.gov/pubmed/33042756 http://dx.doi.org/10.1002/advs.202001447 |
Ejemplares similares
-
Microneedle-based bioassays
por: Zhu, Jixiang, et al.
Publicado: (2020) -
CRISPR-Cas12a delivery by DNA-mediated bioresponsive editing for cholesterol regulation
por: Sun, Wujin, et al.
Publicado: (2020) -
When blockchain meets artificial intelligence: An application to cancer histopathology
por: Hong, Runyu, et al.
Publicado: (2022) -
Artificial intelligence in ophthalmological practice: when ideal meets reality
por: Heindl, Ludwig M, et al.
Publicado: (2023) -
5th Anniversary Article: Engineering Precision Medicine (Adv. Sci. 1/2019)
por: Sun, Wujin, et al.
Publicado: (2019)